Social media says microdosing fixes ADHD. The best trial so far says it doesn't beat placebo. But something real is happening for many people, and it has more to do with what surrounds the experience than the substance itself.

A woman with advanced Alzheimer's briefly regained her voice after psilocybin, and the story went everywhere. Here's what the research on psychedelics and dementia actually shows, what's being tested now, and what families should know.

MDMA is back before the FDA, psilocybin just put most veterans in a small trial into remission, and ibogaine is getting federal funding. Here's an honest look at what psychedelics may offer people with PTSD, and what to watch out for.

Ibogaine may be one of the most powerful tools we have for addiction and trauma, and one of the riskiest. With clinical trials on the way, here's an honest look at the promise, the heart risks, and the science working to make it safer.

That fog, that word just out of reach, isn’t a sign it’s too late. Here’s how nutrition, movement, stress, sleep, and challenge protect your brain, and why psilocybin and integration may belong in the brain health conversation.

Pregnancy and Psychedelics: What You Should Know

What happens when your most trusted healing tool—psychedelic therapy—meets the possibility of pregnancy? In this gentle and educational piece, we explore what’s known (and still unknown) about psychedelics during pregnancy, potential risks, and supportive alternatives for mental wellness. Whether you're expecting or simply curious, this post offers grounded guidance for navigating this sacred threshold with care.

Discover the benefits of low and medium doses of 5-MeO-DMT for mental health, healing, and personal transformation. Learn why a gentler approach can be more sustainable, especially for those new to psychedelics, navigating anxiety, or seeking profound yet manageable insights. Explore a mindful, intentional path to healing today.